Biotech Stock News (PFE) (ANAC) (ADRO) (ADXS)

Pfizer (NYSE:PFE) On Monday May 16, 2016 Pfizer had announced that it would acquire Anacor Pharmaceuticals (NASDAQ:ANAC) for $5.2 billion. Translating the $5.2 billion amount to stock, would make it a buyout at $99.25 per share. When this deal was first announced, Anacor was trading in the mid 60’s level. Why exactly did Pfizer feel … Read more

Biotech Stock News (ANAC) (CELG) (RCPT) (JUNO) (AMGN)

Anacor Pharmaceuticals (NASDAQ:ANAC) On Monday July 13, 2015 shares of Anacor went up 55%, closing around $131.93 per share after the company announced positive phase 3 results in patients who have atopic dermatitis. There were two phase 3 trials that were testing Anacor’s drug, Crisaborole, for these patients with atopic dermatitis — also known as … Read more